Company news
CorMedix Inc. news in 2020
CorMedix Inc.'s news releases, calls and decks from 2020, newest first.
CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed
November 17, 2020
CorMedix Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update
November 4, 2020
CorMedix Appoints Greg Duncan to its Board of Directors
November 1, 2020
CorMedix Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on November 5
October 28, 2020
CorMedix to Participate in BIO Investor Forum Digital
October 7, 2020
CorMedix Appoints Paulo Costa to its Board of Directors
September 16, 2020
CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
September 8, 2020
CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Defencath
August 30, 2020
CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business Update
August 9, 2020
CorMedix Inc. to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 10
August 2, 2020
CorMedix Announces Pricing of $20M Public Offering of Common Stock
July 27, 2020
CorMedix Announces Proposed Public Offering of Common Stock
July 26, 2020
CorMedix Inc. Reports Submission of Defencath™ New Drug Application
July 7, 2020
CorMedix Inc. Reports First Quarter 2020 Financial Results and Provides Business Update
May 10, 2020
CorMedix Inc. Announces Appointment of Chief Financial Officer
May 10, 2020
CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections (CRBSIs), and the Potential for Neutrolin®
May 5, 2020
CorMedix Inc. to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 11
May 3, 2020
CorMedix Inc. Announces Contract Extension of Jack Armstrong as Executive Vice President and Head of Technical Operations
April 22, 2020
CorMedix Completes Sale of $5.5 Million of NOL Tax Benefits through New Jersey Technology Business Tax Certificate Transfer Program
April 21, 2020
CorMedix Inc. reports fourth quarter and full year 2019 financial results and provides business update
March 15, 2020
CorMedix Inc. to Report Fourth Quarter 2019 Financial Results and Provide a Corporate Update on March 16
March 5, 2020
CorMedix Inc. Announces FDA Grant of Rolling Review of Neutrolin® New Drug Application
February 2, 2020
CorMedix Approved to Sell $5.5 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program
February 2, 2020
Decks in 2020
- Investor Presentation (January 2020)
Investor deck · 21 slides · January 2020